We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
Cap. Flow
-$115M
Cap. Flow %
-0.27%
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$189M
2
WMB icon
Williams Companies
WMB
+$155M
3
AYX
Alteryx Inc
AYX
+$94.1M
4
ABBV icon
AbbVie
ABBV
+$87M
5
AMGN icon
Amgen
AMGN
+$78.1M

Sector Composition

Rank Sector Weight
1 Technology 17.44%
2 Healthcare 17.1%
3 Financials 12.78%
4 Industrials 10.38%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URBN icon
2001
Urban Outfitters
URBN
$6.48B
$43 ﹤0.01%
+1
New +$41
RELY icon
2002
Remitly
RELY
$4.64B
$21 ﹤0.01%
1
-965
-100% -$18.3K
BNL icon
2003
Broadstone Net Lease
BNL
$3.9B
$16 ﹤0.01%
1
-2,849
-100% -$44.9K
BANC icon
2004
Banc of California
BANC
$2.94B
$9 ﹤0.01%
1
BORR
2005
Borr Drilling
BORR
$1.3B
$7 ﹤0.01%
1
-2,736
-100% -$17.9K
GRNT icon
2006
Granite Ridge Resources
GRNT
$682M
$7 ﹤0.01%
+1
New +$6
RWT
2007
Redwood Trust
RWT
$484M
$6 ﹤0.01%
+1
New +$7
ALHC icon
2008
Alignment Healthcare
ALHC
$2.18B
$5 ﹤0.01%
+1
New +$6
AUPH icon
2009
Aurinia Pharmaceuticals
AUPH
$2.13B
$5 ﹤0.01%
+1
New +$7
BCS icon
2010
Barclays
BCS
$85.8B
$5 ﹤0.01%
+1
New +$8
CIM
2011
Chimera Investment
CIM
$933M
0
NVTS icon
2012
Navitas Semiconductor
NVTS
$2.82B
$5 ﹤0.01%
+1
New +$6
OLO
2013
DELISTED
Olo Inc
OLO
$5 ﹤0.01%
+1
New +$5
SVRA icon
2014
Savara
SVRA
$1.08B
$5 ﹤0.01%
+1
New +$5
TNYA icon
2015
Tenaya Therapeutics
TNYA
$152M
$5 ﹤0.01%
+1
New +$5
COMP icon
2016
Compass
COMP
$7.9B
$4 ﹤0.01%
1
-1
-50% -$4
TTI icon
2017
TETRA Technologies
TTI
$962M
$4 ﹤0.01%
+1
New +$4
NG icon
2018
NovaGold Resources
NG
$3.03B
$3 ﹤0.01%
+1
New +$3
DHC
2019
Diversified Healthcare Trust
DHC
$1.88B
$2 ﹤0.01%
1
-176
-99% -$504
SCLX icon
2020
Scilex Holding
SCLX
$35.9M
0
AAOI icon
2021
Applied Optoelectronics
AAOI
$8.34B
-81
Closed -$1.56K
ACET icon
2022
Adicet Bio
ACET
$84.7M
-214
Closed -$6.47K
ACRV icon
2023
Acrivon Therapeutics
ACRV
$79.7M
-226,375
Closed -$1.11M
ACVA icon
2024
ACV Auctions
ACVA
$1.77B
-192,305
Closed -$2.91M
ALDX icon
2025
Aldeyra Therapeutics
ALDX
$83.9M
-243
Closed -$853

Similar funds

Federated Hermes's Q1 2024 Portfolio in Review

As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
  • Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
  • Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
  • Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
  • Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.